中文 | English
Return
Total: 16 , 1/2
Show Home Prev Next End page: GO
MeSH:(Pancreatic Neoplasms/*chemistry/*pathology)

2.Proanthocyanidins inhibit pancreatic cancer AsPC-1 cell growth and migration through up-regulation of let-7a.

Jia MA ; Binbin FANG ; Cong MA ; Haijie PANG ; Fanpeng ZENG ; Jun XIA

Journal of Southern Medical University 2015;35(8):1110-1115

3.Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.

Wen-Jing LIU ; Li ZHOU ; Zhi-Yong LIANG ; Wei-Xun ZHOU ; Lei YOU ; Tai-Ping ZHANG ; Yu-Pei ZHAO

Chinese Medical Journal 2018;131(24):2947-2952

4.Lipid-rich variant of pancreatic endocrine tumour with inhibin positivity and microscopic foci of microcystic adenoma-like areas: emphasis on histopathology.

Anuradha Calicut Kini RAO ; Vidya MONAPPA ; Prashanth SHETTY

Singapore medical journal 2013;54(2):e31-4

6.Correlation between proliferating index and prognostic factors in papillary cystic tumors of the pancreas.

Nam Hoon CHO ; Jai Hyang GO ; Sun Hee JUNG ; Woo Hee JUNG ; Kwang Kil LEE

Journal of Korean Medical Science 1995;10(5):342-351

7.Preferential expression of cartilage oligomeric matrix protein in degenerating acinar cells in chronic pancreatitis and in chronic pancreatitis-like lesions.

Quan LIAO ; Yu-pei ZHAO ; Jorg KLEEFF ; Yi XIAO ; Arthur ZIMMERMANN ; Markus W BUCHLER ; Helmut FRIESS

Chinese Journal of Surgery 2003;41(5):328-331

8.Clinical Significance of p16 Protein Expression Loss and Aberrant p53 Protein Expression in Pancreatic Cancer.

Joon JEONG ; Young Nyun PARK ; Joon Seong PARK ; Dong Sup YOON ; Hoon Sang CHI ; Byong Ro KIM

Yonsei Medical Journal 2005;46(4):519-525

9.Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.

Hui YUE ; Jieping YU ; Xin ZHAO ; Fulin SONG ; Xinli FENG

Chinese Medical Journal 2003;116(6):944-946

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 16 , 1/2 Show Home Prev Next End page: GO